Login / Signup

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer.

Mahmoud GanjiShohreh BakhshiAlireza ShoariReza Ahangari Cohan
Published in: Journal of translational medicine (2023)
These compounds can be considered as candidates for bladder cancer therapy with improved therapeutic properties and less adverse effects.
Keyphrases
  • molecular docking
  • cancer therapy
  • drug delivery
  • molecular dynamics simulations
  • small molecule
  • spinal cord injury
  • high throughput
  • case control
  • human health
  • urinary tract
  • risk assessment